Aspergillus is an opportunistic fungus and most common mould, both cosmopolitan and ubiquitous in nature, that causes life-threatening invasive aspergillosis and other grave infections, which pose a precise risk to patients with compromised immune systems. Despite improved therapeutic and diagnostic approaches, invasive aspergillosis remains a cata-strophic fungal infection, such as COVID-19-associated pulmonary aspergillosis and influ-enza-associated pulmonary aspergillosis had a high prevalence in critically ill patients. It in-fects approximately ten million people each year, with a significantly high mortality rate. It is frequently convoluted COVID-19 and severe influenza disease by continuously challeng-ing diagnostic and therapeutic strategies and concomitant with significant morbidity and mor-tality rates. However, Azole-resistant Aspergillus strains are rapidly emerging and creating a significant challenge in managing Aspergillus-associated infections. Promising new antifun-gal agents, including Olorofim, Fosmanogepix, Ibrexafungerp, Opelconazole, and Rezafun-gin, are currently in clinical and preclinical trials. Treating conditions such as invasive asper-gillosis, infections caused by resistant species, and those complicated by drug-drug interac-tions remains particularly difficult in clinical practice, highlighting the urgent need for alter-native therapeutic strategies. In this review article, we highlight the characteristics and habi-tats of Aspergillus species, their pathogenicity, and the clinical challenges they pose, includ-ing diagnostic complexities. It also highlights existing and emerging therapeutic approaches for managing Aspergillus-associated infections. By integrating insights into the biology, di-agnosis, and treatment of these infections, the review emphasizes the importance of innova-tive strategies to overcome current obstacles in clinical management.
Read full abstract- All Solutions
Editage
One platform for all researcher needs
Paperpal
AI-powered academic writing assistant
R Discovery
Your #1 AI companion for literature search
Mind the Graph
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus - Support
Overview
42106 Articles
Published in last 50 years
Related Topics
Articles published on Alternative Strategies
Authors
Select Authors
Journals
Select Journals
Duration
Select Duration
38728 Search results
Sort by Recency